For the latest COVID-19 campus news and resources, visit

Search Close Search
Search Close Search
Page Menu

Psychopharmacology Fellowship

The Brudnick Translational Fellowship in Mood Disorders

The UMass Chan Medical School’s Departments of Psychiatry and Neurobiology announce the newly established Brudnick Translational Fellowship in Mood Disorders, made possible by the generous support of the Irving & Betty Brudnick Family Fund. The goal of the fellowship is to prepare Physician Scientists for an independent career in translational neuroscience research. The fellowship will provide protected time to pursue basic and clinical research full time with salary support, as well as a budget for laboratory supplies and travel to scientific meetings. This three-year fellowship includes a joint academic faculty appointment at the rank of Instructor in Psychiatry and Neurobiology

The successful candidate should have an MD/PhD degree and have completed their residency in psychiatry. The candidate should have previous training in basic and/or clinical research and the desire to pursue translational neuroscience research questions as an independent investigator.

This fellowship represents a collaboration between the Center for Psychopharmacologic Research and Treatment in the Department of Psychiatry and the Brudnick Neuropsychiatric Research Institute within the Department of Neurobiology.

The Brudnick Neuropsychiatric Research Institute

The Brudnick Neuropsychiatric Research Institute (BNRI), under the direction of Andrew Tapper, PhD, engages in cutting-edge basic neuroscience research in an effort to understand the neurobiological bases underlying neuropsychiatric disorders including addiction, anxiety, and depression. A current focus of the BNRI is on mapping the neurocircuitry of anxiety and depression using a combination of modern neuroscience approaches including in vivo imaging, electrophysiology and optogenetics in novel mouse models.

The Center for Psychopharmacologic Research and Treatment

The Center for Psychopharmacologic Research and Treatment (CPRT), under the direction of Anthony Rothschild, MD, is pursuing NIMH and Industry funded studies on the pathophysiology and treatment of difficult-to-treat depressions including Treatment Resistant Depression (TRD) and Major Depression with psychotic features (psychotic depression). A current focus is the efficacy and safety of rapidly acting glutamatergic agents as novel therapeutics for the treatment of Major Depressive Disorder.

The Department of Psychiatry

The Department of Psychiatry is a national leader in public sector psychiatry, child and adolescent psychiatry, neurodevelopmental disorders, biological psychiatry, neuropsychiatry, forensic psychiatry, psychosocial rehabilitation, women’s mental health, and addiction psychiatry. We integrate our clinical, research, teaching and community partnership activities to help individuals and families transform their lives through recovery from mental illness and addiction. We are the largest provider of psychiatric services in central Massachusetts with over 350 faculty and 10 hospitals and community mental health centers. We train residents in adult and child psychiatry, combined neurology/psychiatry; and also train fellows in Law and Psychiatry, Child and Adolescent Psychiatry, Addiction Psychiatry, Forensic Psychiatry, Neuropsychiatry, and Adult Developmental Disabilities.

The Department of Neurobiology

The Department of Neurobiology, founded in 2001, has evolved into a unique and integrated hub of investigators addressing fundamental problems in neurobiology, from single molecules to behavior, primarily using invertebrate model organisms. Combining cell biological, physiological and behavioral analyses with a critical interventionist angle afforded

by cutting-edge genetic approaches, the Department aims to understand the complexity of brain development and function.

Worcester is a short hop from Boston, Providence, and Cape Cod and within easy reach of the scenic Berkshire Mountains. The diverse city of Worcester has nine colleges and universities including the University of Massachusetts Medical School, that overlooks the panoramic shores of Lake Quinsigamond. As the second largest city in New England, it has powered a rise of booming technology, research, manufacturing and healthcare industries.

Applicants should submit a letter of interest and curriculum vitae addressed to:

Kimbrly Yonkers, MD, Chair of Psychiatry University of Massachusetts Medical School c/o: